Get started
Author

Denise Cosgrove

Mapping the human genetic architecture of COVID-19
2021 · COVID-19 Host Genetics Initiative, COVID-19 Host Genetics InitiativeLeadership, et al. · Nature · 983
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2021 · Eugenia Abaleke, Mustafa Abbas, et al. · The Lancet · 533
PDF
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
2021 · Obbina Abani, Ali Abbas, et al. · The Lancet · 493
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2022 · Obbina Abani, Ali Abbas, et al. · The Lancet · 369
Whole-genome sequencing reveals host factors underlying critical COVID-19
2022 · Athanasios Kousathanas, Erola Pairo-Castineira, et al. · Nature · 326
PDF
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
2022 · Obbina Abani, Ali Abbas, et al. · The Lancet · 324
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2021 · Obbina Abani, Ali Abbas, et al. · The Lancet · 290
GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19
2023 · Erola Pairo-Castineira, Konrad Rawlik, et al. · Nature · 224
PDF
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
2023 · Obbina Abani, Ali Abbas, et al. · The Lancet · 129
A second update on mapping the human genetic architecture of COVID-19
2023 · The COVID-19 Host Genetics Initiative, Leadership, et al. · Nature · 118
PDF
Altered naive and memory CD4+ T-cell homeostasis and immunosenescence characterize younger patients with myelodysplastic syndrome
2009 · J X Zou, D E Rollison, et al. · Leukemia · 68
Comparing accelerometer, pedometer and a questionnaire for measuring physical activity in bronchiectasis: a validity and feasibility study
2017 · B. O’Neill, S. M. McDonough, et al. · Respiratory Research · 62
PDF
Sedentary behaviour and physical activity in bronchiectasis: a cross-sectional study
2015 · Judy M Bradley, Jason J Wilson, et al. · BMC Pulmonary Medicine · 48
PDF
Hypertonic Saline or Carbocisteine in Bronchiectasis
2025 · Judy M. Bradley, Brenda O’Neill, et al. · New England Journal of Medicine · 41
PDF
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2023 · O Abani, A Abbas, et al. · The Lancet Diabetes & Endocrinology · 41
PDF
Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial
2024 · Saul N Faust, Richard Haynes, et al. · The Lancet Child & Adolescent Health · 39
PDF
Facilitating education in pulmonary rehabilitation using the Living Well with COPD programme for pulmonary rehabilitation: a process evaluation
2013 · Denise Cosgrove, Joseph MacMahon, et al. · BMC Pulmonary Medicine · 31
PDF
Assessing Education in Pulmonary Rehabilitation: The Understanding COPD (UCOPD) Questionnaire
2012 · Brenda O'Neill, Denise Cosgrove, et al. · COPD Journal of Chronic Obstructive Pulmonary Disease · 27
PDF
Clinician-Facilitated Physical Activity Intervention Versus Pulmonary Rehabilitation for Improving Physical Activity in COPD: A Feasibility Study
2018 · Brenda O’Neill, Orlagh O’Shea, et al. · COPD Journal of Chronic Obstructive Pulmonary Disease · 21
Multiple-Breath Washout Outcome Measures in Adults with Bronchiectasis
2022 · Katherine O’Neill, Gokul R. Lakshmipathy, et al. · Annals of the American Thoracic Society · 13
Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2025 · O Abani, A Abbas, et al. · The Lancet Infectious Diseases · 12
PDF
Stratified analyses refine association between TLR7 rare variants and severe COVID-19
2024 · Jannik Boos, Caspar I. van der Made, et al. · Human Genetics and Genomics Advances · 12
PDF
Author Correction: GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19
2023 · Erola Pairo-Castineira, Konrad Rawlik, et al. · Nature · 9
PDF
Quality control for multiple breath washout tests in multicentre bronchiectasis studies: Experiences from the BRONCH-UK clinimetrics study
2018 · Katherine O'Neill, Gokul R. Lakshmipathy, et al. · Respiratory Medicine · 8
Adjusted dose lenalidomide is safe and effective in patients with deletion (5q) myelodysplastic syndrome and severe renal impairment
2008 · Stefan Knop, Hermann Einsele, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 8
Works count: 44
Citation count: 4,245
H-index: 19
I10-index: 22
Year
Topic
Type